Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | IL3 | 42.5 | 92 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL3 | 37.0 | 87 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL3 | 45.0 | 65 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | IL3 | 46.0 | 78 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | IL3 | 40.0 | 79 | |
| RA2159 | Leptin | 1 | ng/mL | 3 | IL3 | 39.0 | 72 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 40.0 | 53 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 46.0 | 67 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 39.5 | 70 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 41.5 | 72 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 39.0 | 87 | |
| N2586 | Leptin | 1 | ng/mL | 3 | IL3 | 40.0 | 92 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 46.0 | 98 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 47.0 | 69 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 43.0 | 74 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 47.5 | 66 | |
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | IL3 | 36.5 | 64 | |
| RA2159 | Adiponectin | 5 | ng/mL | 3 | IL3 | 135.0 | 77 | ||||
| RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | IL3 | 107.0 | 85 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | IL3 | 110.0 | 73 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | IL3 | 109.0 | 90 | |
| RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | IL3 | 109.0 | 60 | |
| RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | IL3 | 109.5 | 72 | |
| N2586 | Adiponectin | 5 | ng/mL | 3 | IL3 | 105.0 | 81 | ||||
| N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | IL3 | 116.0 | 84 |